Systematic Reviews
Copyright ©The Author(s) 2024.
World J Gastroenterol. Mar 7, 2024; 30(9): 1213-1223
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1213
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 PRISMA flow diagram of the search strategy process.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Vonoprazan triple therapy and tegoprazan triple therapy vs conventional proton pump inhibitor triple therapy - randomized controlled studies. A: Vonoprazan triple therapy; B: Tegoprazan triple therapy. RR: Risk ratio; CI: Confidence interval.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Vonoprazan triple therapy and tegoprazan triple therapy vs conventional proton pump inhibitor triple therapy - observational studies. A: Vonoprazan triple therapy; B: Tegoprazan triple therapy. RR: Risk ratio; CI: Confidence interval.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Vonoprazan second line triple therapy vs conventional proton pump inhibitor second line therapy. RR: Risk ratio; CI: Confidence interval.